Sign up to save your podcasts
Or
Share TNSPPE: What if We Reviewed the Top 300 Drugs as a Quick Conversation?
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
TNSPPE: What if We Reviewed the Top 300 Drugs as a Quick Conversation?
Please note: The views of this podcast represent those of my guest(s) and I. These are not for professional or medical consultation or advice. We disclaim any loss in any way. Please see a state and board-certified health professional for medical advice and consultation.
In this episode, we discuss, the top 300 drugs as a quick conversation. The sequence is as follows: Trade Name then Generic Name then General Category then Therapeutic Category and DEA Schedule, after which are Counseling Points that students may be advised to learn.
Please note: The views of this podcast represent those of my guest(s) and I. These are not for professional or medical consultation or advice. We disclaim any loss in any way. Please see a state and board-certified health professional for medical advice and consultation.
View all episodes
By Mr. D.J. Ferguson, BS, MS, BCMAS, MRSB MRSC
5
33 ratings
Please note: The views of this podcast represent those of my guest(s) and I. These are not for professional or medical consultation or advice. We disclaim any loss in any way. Please see a state and board-certified health professional for medical advice and consultation.
In this episode, we discuss, the top 300 drugs as a quick conversation. The sequence is as follows: Trade Name then Generic Name then General Category then Therapeutic Category and DEA Schedule, after which are Counseling Points that students may be advised to learn.
Please note: The views of this podcast represent those of my guest(s) and I. These are not for professional or medical consultation or advice. We disclaim any loss in any way. Please see a state and board-certified health professional for medical advice and consultation.